Sevelamer ( DrugBank: Sevelamer )


2 diseases
告示番号疾患名(ページ内リンク)臨床試験数
235副甲状腺機能低下症1
238ビタミンD抵抗性くる病/骨軟化症1

235. 副甲状腺機能低下症


臨床試験数 : 88 薬物数 : 107 - (DrugBank : 24) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 7
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000000475
2006/07/0101/09/2006Therapeutic strategy of relative hypoparathyroidism in hemodialysis patients using sevelamer hydrochloride, with special reference to vitamin D administrationTherapeutic strategy of relative hypoparathyroidism in hemodialysis patients using sevelamer hydrochloride, with special reference to vitamin D administration - The effect of sevelamer hydrochloride on relative hypoparathyroidism in hemodialysis patients Relative hypoparathyoidism in maintenance hemodialysis patientsReplacement of calcium carbonate with sevelamer hydrochloride as phosphate binderHokusetsu ROD Study GroupNULLComplete: follow-up complete20years-oldNot applicableMale and Female40Not applicableJapan

238. ビタミンD抵抗性くる病/骨軟化症


臨床試験数 : 28 薬物数 : 20 - (DrugBank : 9) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 16
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01057186
(ClinicalTrials.gov)
December 200926/1/2010Hypophosphatemic Rickets in NorwayHypophosphatemic Rickets in NorwayHypophosphatemia, Familial;Rickets;HyperphosphatemiaDietary Supplement: Alfacalcidol; phosphate.;Drug: SevelamerHaukeland University HospitalNULLActive, not recruitingN/AN/ABoth80N/ANorway